Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 7 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Regenxbio Inc have a median target of 39.00, with a high estimate of 52.00 and a low estimate of 21.00. The median estimate represents a 212.00% increase from the last price of 12.50.
High | 316.0% | 52.00 |
Med | 212.0% | 39.00 |
Low | 68.0% | 21.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 06, 2024.
Average growth rate | +10.26% |
Average growth rate | -4.06% |
More ▼
Revenue history & estimates in USD
Average growth rate | +8.65% |
Average growth rate | +111.76% |
More ▼